Chris Nolet Jasper Therapeutics, Inc. (JSPR) insider trading activity

JSPR Quotes by TradingView

Chris Nolet is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 32,500 shares of JSPR, which is worth approximately $719,875. The most recent transaction as insider was on Oct 12, 2022, when has been sold 32,500 shares (Voting Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.5K
0% 3M change
0% 12M change
Total Value Held $719,875

Chris Nolet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2022
BUY
Grant, award, or other acquisition
-
32,500 Added 50.0%
32,500 Voting Common Stock

Also insider at

RVNC
Revance Therapeutics, Inc. Healthcare
Director
PTE
POLARITYTE, INC. Healthcare
Director
VIE
Viela Bio, Inc.
Director
AVBP
ArriVent Biopharma, Inc.
Director
CN

Chris Nolet

Director
Nashville, TN

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JSPR